HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiko Koike Selected Research

dihydropyrimidinase

5/2015Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
8/2014Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiko Koike Research Topics

Disease

78Neoplasms (Cancer)
11/2022 - 03/2003
44Stomach Neoplasms (Stomach Cancer)
01/2021 - 09/2005
24Hepatocellular Carcinoma (Hepatoma)
08/2022 - 01/2013
23Neoplasm Metastasis (Metastasis)
08/2021 - 07/2005
15Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 02/2014
14Esophageal Squamous Cell Carcinoma
11/2022 - 07/2008
10Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 03/2007
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 09/2002
9Carcinoma (Carcinomatosis)
02/2016 - 01/2005
8Esophageal Neoplasms (Esophageal Cancer)
12/2022 - 09/2003
7Lymphatic Metastasis
04/2022 - 05/2006
7Adenocarcinoma
07/2021 - 09/2014
7Melanoma (Melanoma, Malignant)
11/2019 - 03/2015
5Pancreatic Fistula (Pancreatic Fistulas)
01/2021 - 07/2014
4Fibrosis (Cirrhosis)
01/2021 - 11/2014
4Carcinogenesis
01/2018 - 02/2014
3Rectal Neoplasms (Rectal Cancer)
08/2022 - 08/2019
3Colonic Neoplasms (Colon Cancer)
08/2021 - 01/2020
3Inflammation (Inflammations)
10/2018 - 09/2014
3Peritoneal Neoplasms
11/2008 - 02/2006
3Neoplasm Micrometastasis
11/2008 - 09/2005
2Margins of Excision
01/2021 - 05/2020
2Pneumonia (Pneumonitis)
10/2019 - 10/2019
2Neoplasms, Cystic, Mucinous, and Serous
01/2018 - 05/2015
2Sarcopenia
03/2017 - 06/2016
2Disease Progression
12/2015 - 05/2015
2Abdominal Abscess
09/2015 - 07/2010
2Ovarian Neoplasms (Ovarian Cancer)
10/2009 - 04/2007
1Liver Diseases (Liver Disease)
08/2022
1Liver Failure
01/2021
1Hepatitis B
01/2021

Drug/Important Bio-Agent (IBA)

30Biomarkers (Surrogate Marker)IBA
11/2022 - 05/2013
29Messenger RNA (mRNA)IBA
04/2022 - 01/2005
13Proteins (Proteins, Gene)FDA Link
11/2022 - 03/2003
12AntigensIBA
11/2022 - 09/2002
7Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 - 10/2011
6Fluorouracil (Carac)FDA LinkGeneric
12/2022 - 03/2007
6Carcinoembryonic AntigenIBA
04/2022 - 09/2002
5Capecitabine (Xeloda)FDA Link
01/2021 - 09/2005
4Cisplatin (Platino)FDA LinkGeneric
12/2022 - 01/2017
4Docetaxel (Taxotere)FDA Link
12/2022 - 09/2005
4Tumor Biomarkers (Tumor Markers)IBA
06/2020 - 09/2002
4Biological ProductsIBA
01/2019 - 01/2006
4Pharmaceutical PreparationsIBA
07/2016 - 12/2006
4Indicators and Reagents (Reagents)IBA
03/2015 - 07/2008
3BilirubinIBA
08/2022 - 01/2019
3AlbuminsIBA
08/2022 - 01/2019
3RNA (Ribonucleic Acid)IBA
07/2021 - 01/2019
3EnzymesIBA
09/2020 - 03/2007
3CarbohydratesIBA
01/2019 - 09/2014
3Bevacizumab (Avastin)FDA Link
01/2018 - 10/2012
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2007 - 02/2006
3Paclitaxel (Taxol)FDA LinkGeneric
04/2007 - 09/2005
2squamous cell carcinoma-related antigenIBA
04/2022 - 04/2020
2N-methyladenosineIBA
07/2021 - 12/2020
26-methyladenineIBA
07/2021 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
04/2021 - 03/2003
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 01/2019
2Transcription Factors (Transcription Factor)IBA
01/2021 - 03/2016
2GTP-Binding Proteins (G-Protein)IBA
01/2021 - 11/2020
2N-acetyltalosaminuronic acid (NAT)IBA
05/2020 - 10/2018
2MicroRNAs (MicroRNA)IBA
04/2020 - 01/2019
2Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 04/2014
2Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
02/2017 - 09/2016
2Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
08/2016 - 03/2016
2Cell Adhesion MoleculesIBA
02/2016 - 08/2014
2Hematoxylin (Haematoxylon)IBA
01/2016 - 05/2005
2Eosine Yellowish-(YS) (Eosin)IBA
01/2016 - 05/2005
2Vitamin KFDA Link
12/2015 - 05/2015
2dihydropyrimidinaseIBA
05/2015 - 08/2014
2Cadherins (E-Cadherin)IBA
11/2014 - 06/2014
2VimentinIBA
11/2014 - 06/2014
2Immunoglobulins (Immunoglobulin)IBA
02/2014 - 10/2009
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
02/2014 - 10/2009
2Epidermal Growth Factor (EGF)IBA
01/2013 - 02/2012
2AntibodiesIBA
11/2008 - 05/2005
2Plasminogen Activator Inhibitor 1IBA
07/2008 - 05/2006
2ParaffinIBA
07/2007 - 03/2007
1pegfilgrastim (Neulasta)FDA Link
12/2022
1Immunoglobulin A (IgA)IBA
11/2022
1VaccinesIBA
11/2022
1pullulanIBA
11/2022
1Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
11/2022
1acarboxyprothrombin (PIVKA)IBA
05/2021
1Fetal Proteins (Fetoprotein)IBA
05/2021
1ethanolamine kinaseIBA
01/2021
1ApolipoproteinsIBA
01/2021

Therapy/Procedure

21Therapeutics
11/2022 - 04/2006
17Esophagectomy
08/2022 - 09/2003
12Gastrectomy
05/2017 - 01/2008
10Drug Therapy (Chemotherapy)
08/2022 - 09/2005
8Adjuvant Chemotherapy
01/2021 - 07/2014
7Lymph Node Excision (Lymph Node Dissection)
10/2019 - 01/2008
6Hepatectomy
01/2021 - 09/2014
6Neoadjuvant Therapy
11/2020 - 04/2006
3Pancreatectomy
01/2021 - 07/2014
2Pancreaticoduodenectomy
01/2021 - 09/2014
2Length of Stay
10/2019 - 01/2018
2Nutritional Support (Artificial Feeding)
10/2018 - 05/2015
2Blood Transfusion (Blood Transfusions)
07/2016 - 01/2016